InsiderTrades.com logo

ZNTL Insider Trading

Insider Ownership Percentage: 1.90%
Insider Buying (Last 12 Months): $7,781,367.60
Insider Selling (Last 12 Months): $10,088,416.65

Zentalis Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Zentalis Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zentalis Pharmaceuticals Share Price & Price History

Current Price: $2.47
Price Change: ▲ Price Increase of +0.02 (0.82%)
As of 02/24/2026 05:00 PM ET

This chart shows the closing price history over time for ZNTL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Zentalis Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/10/2026Vincent VultaggioInsiderSell6,894$2.42$16,683.48146,506View SEC Filing Icon  
2/9/2026Ingmar BrunsInsiderSell335$2.39$800.6533,332View SEC Filing Icon  
2/9/2026Vincent VultaggioInsiderSell3,379$2.39$8,075.81153,400View SEC Filing Icon  
2/6/2026Ingmar BrunsInsiderSell2,962$2.43$7,197.6633,667View SEC Filing Icon  
2/6/2026Vincent VultaggioInsiderSell29,951$2.43$72,780.93156,779View SEC Filing Icon  
2/3/2026Vincent VultaggioInsiderSell556$2.52$1,401.12186,730View SEC Filing Icon  
2/2/2026Vincent VultaggioInsiderSell2,540$2.55$6,477.00187,286View SEC Filing Icon  
12/31/2025Group WaltersMajor ShareholderBuy6,459,973$1.20$7,751,967.6013,509,973View SEC Filing Icon  
12/15/2025Matrix Capital Management CompMajor ShareholderSell7,500,000$1.33$9,975,000.006,459,973View SEC Filing Icon  
4/30/2025Scott Dunseth MyersDirectorBuy21,000$1.40$29,400.00281,192View SEC Filing Icon  
2/6/2025Ingmar BrunsInsiderBuy20,000$2.28$45,600.0036,629View SEC Filing Icon  
2/3/2025Vincent VultaggioInsiderSell2,615$1.71$4,471.65189,826View SEC Filing Icon  
1/31/2025Jan SkvarkaDirectorBuy60,000$1.72$103,200.00149,551View SEC Filing Icon  
1/2/2025Mark LacknerInsiderSell4,411$3.12$13,762.32191,317View SEC Filing Icon  
10/4/2024Vincent VultaggioInsiderSell1,603$3.18$5,097.5433,855View SEC Filing Icon  
5/31/2024Cam GallagherCFOSell9,597$11.98$114,972.06633,680View SEC Filing Icon  
5/9/2024Diana HausmanInsiderSell3,356$12.62$42,352.72373,876View SEC Filing Icon  
2/12/2024Cam GallagherPresidentSell1,173$11.44$13,419.12643,277View SEC Filing Icon  
2/12/2024Melissa B. EpperlyCFOSell2,573$11.44$29,435.12451,449View SEC Filing Icon  
11/13/2023Kimberly BlackwellCEOBuy5,000$10.29$51,450.00254,800View SEC Filing Icon  
11/10/2023David Michael JohnsonDirectorBuy17,000$9.88$167,960.00144,389View SEC Filing Icon  
10/4/2023Carrie BrownsteinInsiderSell10,628$19.50$207,246.00105,685View SEC Filing Icon  
10/4/2023Melissa B. EpperlyCFOSell5,482$19.50$106,899.00387,691View SEC Filing Icon  
9/11/2023Jan SkvarkaDirectorSell5,000$25.05$125,250.0047,970View SEC Filing Icon  
6/20/2023Matrix Capital Management CompMajor ShareholderBuy4,760,000$22.66$107,861,600.0013,959,973View SEC Filing Icon  
5/31/2023Cam GallagherPresidentSell27,768$26.27$729,465.36463,502View SEC Filing Icon  
5/26/2023Kevin D. BunkerInsiderSell80,000$30.02$2,401,600.0015,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Zentalis Pharmaceuticals (NASDAQ:ZNTL)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ZNTL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Zentalis Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/19/2026Invesco Ltd.188,582$0.26M0.0%+8.6%0.261%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd576,707$0.78M0.0%+5.1%0.798%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd137,568$0.19M0.0%+126.8%0.190%Search for SEC Filing on Google Icon
2/18/2026Opaleye Management Inc.1,400,906$1.89M0.2%+342.6%1.939%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC673,129$0.91M0.0%-25.4%0.932%Search for SEC Filing on Google Icon
2/18/2026Ishara Investments LP1,320,000$1.78M2.1%N/A1.827%Search for SEC Filing on Google Icon
2/18/20265AM Venture Management LLC3,947,913$5.33M1.7%+705.7%5.464%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC80,000$0.11M0.0%+60.0%0.111%Search for SEC Filing on Google Icon
2/17/2026Almitas Capital LLC610,073$0.82M0.2%+33.4%0.844%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC45,995$62K0.0%-57.0%0.064%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.90,910$0.12M0.0%-40.2%0.126%Search for SEC Filing on Google Icon
2/17/2026Opal Capital LLC72,251$98K0.0%N/A0.100%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC107,734$0.15M0.0%+405.3%0.149%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.86,640$0.12M0.0%-11.5%0.120%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC568,443$0.77M0.0%+252.0%0.787%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP247,788$0.34M0.0%N/A0.343%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC110,448$0.15M0.0%-8.3%0.153%Search for SEC Filing on Google Icon
2/13/2026Quarry LP132,000$0.18M0.0%+21.4%0.183%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC473,175$0.64M0.0%-26.7%0.655%Search for SEC Filing on Google Icon
2/12/2026Carson Advisory Inc.23,470$32K0.0%-26.8%0.032%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC2,883,745$3.89M0.0%+24.0%3.991%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP96,263$0.13M0.0%-48.0%0.133%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.34,574$47K0.0%-15.9%0.048%Search for SEC Filing on Google Icon
2/11/2026Primecap Management Co. CA957,420$1.29M0.0%-0.5%1.325%Search for SEC Filing on Google Icon
2/10/2026Sivia Capital Partners LLC20,000$27K0.0%N/A0.028%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.118,212$0.16M0.0%-65.8%0.164%Search for SEC Filing on Google Icon
2/6/2026GSA Capital Partners LLP1,169,573$1.58M0.1%+8.5%1.619%Search for SEC Filing on Google Icon
2/5/2026Barr E S & Co.57,500$78K0.0%+43.8%0.080%Search for SEC Filing on Google Icon
2/4/202649 Wealth Management LLC70,911$96K0.0%+151.5%0.098%Search for SEC Filing on Google Icon
2/3/2026Anfield Capital Management LLC242,605$0.33M0.1%+239.9%0.336%Search for SEC Filing on Google Icon
1/28/2026Peapod Lane Capital LLC448,861$0.61M0.5%-20.6%0.621%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC130,407$0.18M0.0%-21.6%0.180%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.723,075$1.09M0.0%+31.4%1.001%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.700,576$1.06M0.0%-18.3%0.970%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd548,629$0.83M0.0%+107.2%0.759%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP27,161$41K0.0%N/A0.038%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd56,639$86K0.0%+76.4%0.078%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC902,521$1.36M0.0%-74.0%1.249%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE1,548,781$2.34M0.0%+117.1%2.144%Search for SEC Filing on Google Icon
11/17/2025Almitas Capital LLC457,322$0.69M0.2%-71.4%0.633%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC48,496$73K0.0%N/A0.067%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.52,572$79K0.0%-42.4%0.073%Search for SEC Filing on Google Icon
11/14/2025Creative Planning260,000$0.39M0.0%+757.0%0.360%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP1,363,347$2.06M0.0%+24.7%1.887%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC21,322$32K0.0%-54.1%0.030%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG532,678$0.80M0.0%+311.4%0.738%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets158,935$0.24M0.0%-8.4%0.220%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP185,032$0.28M0.0%-44.9%0.256%Search for SEC Filing on Google Icon
11/12/2025Primecap Management Co. CA962,620$1.45M0.0%-6.3%1.334%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP1,077,656$1.63M0.1%-4.9%1.494%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.2,904,400$4.39M0.0%+0.7%4.026%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.723,075$1.09M0.0%+31.4%1.002%Search for SEC Filing on Google Icon
11/6/2025Tybourne Capital Management HK Ltd.961,486$1.45M4.7%-35.0%1.333%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC16,521$25K0.0%-67.4%0.023%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC166,290$0.26M0.0%-4.4%0.231%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC31,579$48K0.0%+35.3%0.044%Search for SEC Filing on Google Icon
9/26/2025Corient Private Wealth LLC35,760$41K0.0%N/A0.050%Search for SEC Filing on Google Icon
8/19/2025State of Wyoming73,797$86K0.0%+63.4%0.102%Search for SEC Filing on Google Icon
8/15/2025Corient Private Wealth LLC71,520$83K0.0%N/A0.099%Search for SEC Filing on Google Icon
8/15/2025Opaleye Management Inc.1,924,300$2.23M0.5%-3.1%2.667%Search for SEC Filing on Google Icon
8/15/2025Man Group plc406,344$0.47M0.0%+302.3%0.563%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets173,484$0.20M0.0%+145.0%0.240%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC77,300$90K0.0%-49.2%0.107%Search for SEC Filing on Google Icon
8/15/2025Balyasny Asset Management L.P.970,862$1.13M0.0%N/A1.346%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE713,315$0.83M0.0%-36.9%0.989%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.91,195$0.11M0.0%+622.8%0.126%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC664,061$0.77M0.0%+346.3%0.921%Search for SEC Filing on Google Icon
8/14/2025Sei Investments Co.167,100$0.19M0.0%+373.1%0.232%Search for SEC Filing on Google Icon
8/14/2025RBF Capital LLC80,000$93K0.0%N/A0.111%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd32,113$37K0.0%N/A0.045%Search for SEC Filing on Google Icon
8/14/2025Federated Hermes Inc.39,736$46K0.0%-94.7%0.055%Search for SEC Filing on Google Icon
8/13/2025Walleye Capital LLC129,867$0.15M0.0%-62.0%0.180%Search for SEC Filing on Google Icon
8/13/2025Decheng Capital LLC1,323,327$1.54M0.4%-34.5%1.834%Search for SEC Filing on Google Icon
8/13/2025Stonepine Capital Management LLC109,010$0.13M0.1%+81.7%0.151%Search for SEC Filing on Google Icon
8/13/2025Quadrature Capital Ltd52,456$61K0.0%N/A0.073%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd264,829$0.31M0.0%+112.9%0.367%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.550,447$0.64M0.0%-26.3%0.763%Search for SEC Filing on Google Icon
8/12/2025Catalyst Funds Management Pty Ltd26,800$31K0.0%N/A0.037%Search for SEC Filing on Google Icon
8/11/2025Primecap Management Co. CA1,027,620$1.19M0.0%-18.7%1.428%Search for SEC Filing on Google Icon
8/8/2025Creative Planning30,340$35K0.0%-87.2%0.042%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC618,167$0.72M0.0%-54.4%0.859%Search for SEC Filing on Google Icon
8/7/202549 Wealth Management LLC21,546$25K0.0%-52.7%0.030%Search for SEC Filing on Google Icon
8/7/2025Acadian Asset Management LLC2,799,020$3.24M0.0%+4.7%3.890%Search for SEC Filing on Google Icon
8/7/2025Connor Clark & Lunn Investment Management Ltd.314,845$0.37M0.0%-12.8%0.438%Search for SEC Filing on Google Icon
8/6/2025Savant Capital LLC50,727$59K0.0%N/A0.071%Search for SEC Filing on Google Icon
8/1/2025Y Intercept Hong Kong Ltd32,740$38K0.0%N/A0.046%Search for SEC Filing on Google Icon
8/1/2025Tybourne Capital Management HK Ltd.1,478,152$1.72M5.0%+53.7%2.054%Search for SEC Filing on Google Icon
7/25/2025CWM LLC28,646$33K0.0%-27.8%0.040%Search for SEC Filing on Google Icon
7/15/2025Public Employees Retirement System of Ohio36,700$43K0.0%+351.7%0.051%Search for SEC Filing on Google Icon
7/10/2025Wealth Enhancement Advisory Services LLC174,006$0.22M0.0%-25.7%0.242%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.456,393$0.73M0.0%-50.3%0.634%Search for SEC Filing on Google Icon
6/18/2025Voya Investment Management LLC17,282$27K0.0%-69.7%0.024%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC2,674,035$4.24M0.0%+150.6%3.716%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC148,804$0.24M0.0%-54.0%0.207%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.456,393$0.73M0.0%-50.3%0.634%Search for SEC Filing on Google Icon
5/16/2025Millennium Management LLC3,069,514$4.88M0.0%+220.6%4.266%Search for SEC Filing on Google Icon
5/16/2025Jacobs Levy Equity Management Inc.348,965$0.56M0.0%+50.4%0.485%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC619,330$0.99M0.0%+177.6%0.861%Search for SEC Filing on Google Icon
5/16/2025Almitas Capital LLC1,710,921$2.72M0.9%+5.2%2.378%Search for SEC Filing on Google Icon
5/15/2025Cubist Systematic Strategies LLC78,212$0.12M0.0%-56.6%0.109%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Zentalis Pharmaceuticals logo
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.
Read More on Zentalis Pharmaceuticals

Today's Range

Now: $2.47
Low: $2.43
High: $2.61

50 Day Range

MA: $2.30
Low: $1.33
High: $3.74

52 Week Range

Now: $2.47
Low: $1.01
High: $3.95

Volume

1,453,563 shs

Average Volume

1,755,274 shs

Market Capitalization

$178.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.72

Who are the company insiders with the largest holdings of Zentalis Pharmaceuticals?

Zentalis Pharmaceuticals' top insider investors include:
  1. Group Walters (Major Shareholder)
  2. Matrix Capital Management Comp (Major Shareholder)
  3. Cam Gallagher (CFO)
  4. Diana Hausman (Insider)
  5. Scott Dunseth Myers (Director)
  6. Mark Lackner (Insider)
  7. Vincent Vultaggio (Insider)
  8. Jan Skvarka (Director)
  9. Ingmar Bruns (Insider)
Learn More about top insider investors at Zentalis Pharmaceuticals.

Who are the major institutional investors of Zentalis Pharmaceuticals?

Zentalis Pharmaceuticals' top institutional shareholders include:
  1. 5AM Venture Management LLC — 5.46%
  2. Renaissance Technologies LLC — 3.99%
  3. Opaleye Management Inc. — 1.94%
  4. Ishara Investments LP — 1.83%
  5. GSA Capital Partners LLP — 1.62%
  6. Primecap Management Co. CA — 1.33%
Learn More about top institutional investors of Zentalis Pharmaceuticals stock.

Which major investors are selling Zentalis Pharmaceuticals stock?

In the last quarter, ZNTL stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Goldman Sachs Group Inc.
  3. Jane Street Group LLC
  4. Peapod Lane Capital LLC
  5. Dimensional Fund Advisors LP
  6. Graham Capital Management L.P.
  7. AQR Capital Management LLC
  8. Wealth Enhancement Advisory Services LLC
Within the last year, company insiders that have sold Zentalis Pharmaceuticals company stock include:
  1. Group Walters (Major Shareholder)
  2. Matrix Capital Management Comp (Major Shareholder)
  3. Cam Gallagher (CFO)
Learn More investors selling Zentalis Pharmaceuticals stock.

Which major investors are buying Zentalis Pharmaceuticals stock?

In the last quarter, ZNTL stock was purchased by institutional investors including:
  1. 5AM Venture Management LLC
  2. Ishara Investments LP
  3. Opaleye Management Inc.
  4. Renaissance Technologies LLC
  5. Barclays PLC
  6. Marshall Wace LLP
  7. Anfield Capital Management LLC
  8. Almitas Capital LLC
During the previous year, these company insiders have bought Zentalis Pharmaceuticals stock:
  1. Group Walters (Major Shareholder)
  2. Matrix Capital Management Comp (Major Shareholder)
  3. Cam Gallagher (CFO)
  4. Diana Hausman (Insider)
Learn More investors buying Zentalis Pharmaceuticals stock.